Alector announces appointment of marc grasso, m.d., as chief financial officer

South san francisco, calif., feb. 07, 2022 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering the discovery and development of immuno-neurology therapeutics, today announced the appointment of marc grasso, m.d., as chief financial officer (cfo). dr. grasso brings extensive biotechnology industry leadership experience, including a successful track record in finance, corporate development and strategic leadership. as alector's cfo, dr. grasso will lead all aspects of the company's financial operations and play a critical role in supporting corporate strategy. dr. grasso will report to arnon rosenthal, ph.d., chief executive officer of alector.
ALEC Ratings Summary
ALEC Quant Ranking